Showing results (81-90 of 246) with videos related to
Sort By:
Pageof 25
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Re-assessment of acidic glycosphingolipids in small-cell-lung-cancer tissues and cell linesC Gnewuch, G Jaques, K Havemann, et al.Oncology|January 1, 1980
Incidence of circulating immune complexes in patients with lung cancer and their effect on antibody-dependent cytotoxicityC Gropp, K Havemann, T Scherfe, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell linesM Wolf, M Maasberg, R Pfab, et al.Oncology|July 1, 1993
Tamoxifen or cyproterone acetate in combination with buserelin are ineffective in patients with pancreatic adenocarcinomaB Swarovsky, M Wolf, K Havemann, et al.Archives of Disease in Childhood|February 1, 1985
Treatment of severe coagulation disturbances as a condition of improved prognosis in fulminant liver failureR Burghard, J U Leititis, R Rossi, et al.Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Impaired fibrinolysis after kidney transplantationR Seitz, R Michalik, R Egbring, et al.Leukemia Research|September 5, 2001
Exposure to armament wastes and leukemia: a case-control study within a cluster of AML and CML in GermanyP H Kilian, S Skrzypek, N Becker, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Prognostic impact of an activation of coagulation in lung cancerR Seitz, H H Heidtmann, M Wolf, et al.Fortschritte Der Medizin|October 23, 1980
[Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension]H G Klingemann, U Schmidt, D Brunswig, et al.Blood|October 15, 1992
Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA)J Koopman, F Haverkate, J Grimbergen, et al.Pageof 25